Back to Search
Start Over
Safety and efficacy of secukinumab in patients with giant cell arteritis (TitAIN): a randomised, double-blind, placebo-controlled, phase 2 trial
- Source :
- The Lancet Rheumatology. 5:e341-e350
- Publication Year :
- 2023
- Publisher :
- Elsevier BV, 2023.
- Subjects :
- Rheumatology
Immunology
Immunology and Allergy
Subjects
Details
- ISSN :
- 26659913
- Volume :
- 5
- Database :
- OpenAIRE
- Journal :
- The Lancet Rheumatology
- Accession number :
- edsair.doi...........8d62e16bdbfb71ba40c18d96888bb5c5